NCT02674412View on ClinicalTrials.gov

Buspirone for Functional Dysphagia

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 12, 2017

Study Completion Date

April 12, 2017

Conditions
Functional DysphagiaIneffective Esophageal Motility
Interventions
DRUG

Buspirone

DRUG

Placebo

Placebo Pill Manufactured by the Investigational Pharmacy at Cleveland Clinic

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT02674412 - Buspirone for Functional Dysphagia | Biotech Hunter | Biotech Hunter